In March 2026, NICA submitted comments to the Centers for Medicare & Medicaid Services (CMS) on its Comprehensive Regulations to Uncover Suspicious Healthcare Activity (CRUSH) initiative. While supporting efforts to prevent Medicare fraud, NICA urged CMS to maintain the existing one-year claims submission deadline. NICA warned that shortening this timeframe could increase administrative burdens, create reimbursement challenges for infusion providers, and delay patient access to medically necessary care.
March 30, 2026
The Honorable Mehmet Oz, MD, MBA
Administrator
Centers for Medicare & Medicaid Services
7500 Security Boulevard
Baltimore, MD 21244
Submitted electronically via www.regulations.gov
Re: Request for Information Related to Comprehensive Regulations to Uncover Suspicious Healthcare Activity (CRUSH)
Dear Administrator Oz:
The National Infusion Center Association (NICA) is a nonprofit organization formed to support non- hospital, community-based infusion centers caring for patients in need of provider-administered medications. To improve access to medical benefit drugs that treat complex, rare, and chronic diseases, we work to ensure that patients can access these drugs in safe, more efficient, and cost-effective alternatives to hospital care settings. NICA supports policies that improve drug affordability for beneficiaries, increase price transparency, reduce disparities in safety across care settings, and foster patient access to the highest-quality, lowest-cost setting. Today, we write to provide feedback on the aforementioned RFI.
Reducing Fraudulent Medicare Parts A and B (Traditional Medicare) Claim Submissions
NICA is concerned that shortening Medicare timely filing deadlines or otherwise restricting the claims submission window could have unintended consequences for provider sustainability and beneficiary access to care. Therefore, NICA urges CMS to maintain the current one-year timeframe.
The Medicare enrollment process is inherently lengthy, in part due to the need to prevent fraudulent actors from entering the program. As such, it can take several months to complete, particularly when additional information is required. During this period, providers often begin furnishing care to Medicare beneficiaries with the expectation that claims can be submitted retroactively once enrollment is approved. This flexibility is essential to ensuring that patients do not face delays in accessing provider-administered therapies.
In a brief survey of members, NICA heard that if CMS were to shorten the timeframe for claims submission, infusion providers may be forced to delay furnishing care until enrollment is near or fully complete to mitigate the risk of non-payment. This would delay beneficiary access to medically necessary services, as care that is currently furnished during the enrollment process would instead be deferred until enrollment is finalized.
Shortened timelines would also require providers to accelerate claims submission processes, diverting staff and resources away from patient care activities and increasing administrative burden without clear
benefit to program integrity. Complying with the accelerated timelines may also require increased staffing and operational resources, raising costs for providers already operating under narrow margins. Survey respondents also indicated that shortened timelines may increase the likelihood of claim denials and non-payment, resulting in resubmissions. Providers further noted that even when claims are ultimately paid, disruptions to standard billing timelines may create cash flow challenges and financial strain for infusion centers.
While NICA supports CMS’ efforts to strengthen program integrity and reduce fraudulent billing, changes to the claims submission timeframe may disproportionately impact providers acting in good faith, while doing little to deter bad actors. In our observation, CMS’ program integrity goals would be more effectively achieved through targeted approaches, such as pre-payment review, targeted probe and educate, and the use of data-driven analytic tools, rather than shortening claims submission timelines.
Thank you for the opportunity to comment on this important issue. We would welcome the opportunity to connect with you if we can provide any other information about our concerns. Please do not hesitate to contact me, should you have any questions or wish to further discuss this issue: [email protected]
Sincerely,

Brian Nyquist, MPH Chief Executive Officer
National Infusion Center Association

